Healthcare Boss: Jason A. Duprat Speaks with Lamassu CEO Dr. Gabi Hanna MD About Navigating Intellectual Property & Entrepreneurship

03/30/2020

Dr. Gabi Hanna, a physician entrepreneur with more than 15 years of leadership experience in early drug development and the Executive Director at Duke Preclinical Translational Research Unit speaks with Jason A. Duprat, Entrepreneur, Healthcare Practitioner and Host of the Healthcare Entrepreneur Academy Podcast. In this episode, they talk about the field of translational research. Dr. Hanna offers advice to entrepreneurs interested in navigating entrepreneurship while working for another institution.

CLICK HERE to listen to Jason Duprat and Gabi Hanna’s conversation on Healthcare Boss.

READ MORE

04/08/2025

The Washington Times: Biotech should take a page from Elon Musk’s playbookThe Washington Post:

Innovation has always been the foundation of progress, but how we innovate matters as much as the results we achieve. Recent breakthroughs in aerospace and artificial intelligence prove that massive budgets don’t drive innovation, but efficiency, speed and a relentless...

READ THE ARTICLE
11/05/2024

Cleveland.com: Biotech startup Lamassu, Cleveland Clinic aim to treat rare cancers with just three pills a month

CLEVELAND, Ohio — A biotech startup from North Carolina thinks Cleveland is where it will develop how to treat rare cancers with just three pills a month. If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy...

READ THE ARTICLE
09/23/2024

RealClear Health: Harris, Trump Must Tackle the Root Causes of High Drug PricesRealClear Health:

One of the most urgent challenges facing the American healthcare system is the complex and multifaceted issue of drug pricing. Like addressing a chronic disease, where treatment must go beyond alleviating symptoms to targeting the underlying cause, drug pricing reform...

READ THE ARTICLE